In line with the increased cytokine expression (Figures 2A,B; Supplementary Figure 3A), we detected a significantly higher number of effector-memory CD4+ T cells (TEM) and TH1-like cells in the mLN of HSD fed tumor-bearing mice based on an antibody panel containing CD3, CD4, CD44, CD62L, CCR6, and CXCR3 specific antibodies by FlowSOM analysis at day 15–17 p.i. (Figure 3A). The gene discussed is SELL; the disease is neoplasm.